1. Home
  2. HOG vs TLX Comparison

HOG vs TLX Comparison

Compare HOG & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harley-Davidson Inc.

HOG

Harley-Davidson Inc.

HOLD

Current Price

$21.61

Market Cap

3.3B

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$9.02

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOG
TLX
Founded
1903
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HOG
TLX
Price
$21.61
$9.02
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$28.00
$21.00
AVG Volume (30 Days)
2.6M
108.9K
Earning Date
11-04-2025
01-01-0001
Dividend Yield
3.33%
N/A
EPS Growth
N/A
N/A
EPS
4.04
0.04
Revenue
$4,664,627,000.00
$664,225,558.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.04
N/A
P/E Ratio
$5.34
$284.97
Revenue Growth
N/A
55.35
52 Week Low
$20.45
$8.76
52 Week High
$33.59
$30.36

Technical Indicators

Market Signals
Indicator
HOG
TLX
Relative Strength Index (RSI) 30.15 38.74
Support Level $21.82 $9.37
Resistance Level $22.77 $10.03
Average True Range (ATR) 0.77 0.25
MACD -0.12 -0.00
Stochastic Oscillator 0.73 7.65

Price Performance

Historical Comparison
HOG
TLX

About HOG Harley-Davidson Inc.

Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring segments, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 37% of the heavyweight domestic market in 2024.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: